Avid Bioservices Inc (CDMO)

[senrex]

The most distrubing aspect of the CC was its brevity. There was only one investment house lined up to ask a question (the guy from Merrill Lynch). The rest of the questioners must have been private investors -- and King & Co. wanted no part of their questions. I would have loved to hear someone ask (like I would have if I had gotten through), "By the way, given the recent debacle delivered by the the shorts, do you have any regrets about all the snickering done by management two CC's ago when asked about the huge short position?"

Would someone clear something up: when King (I believe) said that management believed that the best use of AVID was for in-house utilization for PPHM products, was he saying that was what had been decided -- or that this was the view given that so few contracts had been landed?

Where is odd sod?

TIA,
Sean